Manufacturers in China approved to produce low-cost COVID-19 oral drug Paxlovid

Name: Manufacturers in China approved to produce low-cost COVID-19 oral drug Paxlovid
Uploaded: 2022-04-04T21:30:59+03:00
Description: Manufacturers in China approved to produce low-cost COVID-19 oral drug Paxlovid

Published 04 April 2022